Daniel Addison
Overview
Explore the profile of Daniel Addison including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
132
Citations
1291
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Houmsse M, Muskara A, Pasca D, Roy A, Sughra S, Ghazi S, et al.
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075674
: Soft tissue sarcomas (STS) are aggressive cancers that show increasing response to novel targeted-therapies and immune-checkpoint-inhibitors. Despite anecdotal reports of cardiovascular adverse events (AEs) and major adverse cardiovascular events...
2.
Khera R, Asnani A, Krive J, Addison D, Zhu H, Vasbinder A, et al.
Circ Genom Precis Med
. 2025 Feb;
:e000097.
PMID: 39989357
Artificial intelligence is poised to transform cardio-oncology by enabling personalized care for patients with cancer, who are at a heightened risk of cardiovascular disease due to both the disease and...
3.
Bolakale-Rufai I, Knapp S, Tucker-Edmonds B, Edmonds B, Khan S, Brewer L, et al.
Circ Cardiovasc Qual Outcomes
. 2024 Nov;
18(1):e011643.
PMID: 39523944
Background: It is unknown whether predelivery cardiology care is associated with future risk of major adverse cardiovascular events (MACE) in preeclampsia/eclampsia (PrE/E). We sought to determine the cumulative incidence of...
4.
Kumar A, Khadke S, AlKindi S, Rajagopalan S, Nasir K, Kazi D, et al.
JACC Adv
. 2024 Oct;
3(8):101106.
PMID: 39444413
Background: Evidence regarding the effect of long-term exposure to particulate matter (PM) 2.5 and comorbid cancer and cardiovascular disease (CVD) mortality is limited. Objectives: In this study, the author report...
5.
Munir M, Sayed A, Addison D, Epperla N
Blood Adv
. 2024 Oct;
8(24):6282-6296.
PMID: 39418640
Over the past decade, T-cell-directed therapies, including chimeric antigen receptor T-cell (CAR-T) and bispecific T-cell engager (BTE) therapies, have reshaped the treatment of an expanding number of hematologic malignancies, whereas...
6.
Gregory M, Cao W, Rahurkar S, Haroun F, Stock J, Ghazi S, et al.
Cancer Med
. 2024 Sep;
13(17):e7079.
PMID: 39248010
Background: Cancer survivors are at greater risk for cardiovascular-related mortality. Mobile health (mHealth) is an increasingly prevalent strategy for health promotion, but whether it consistently improves cardiorespiratory outcomes after a...
7.
Kalathoor S, Ghazi S, Otieno B, Babcook M, Chen S, Nidhi N, et al.
Int J Cancer
. 2024 Aug;
155(11):1958-1968.
PMID: 39155749
Contemporary anticancer therapies frequently have different efficacy and side effects in men and women. Yet, whether women are well-represented in pivotal trials supporting contemporary anticancer drugs is unknown. Leveraging the...
8.
Gambril J, Ghazi S, Sansoterra S, Ferdousi M, Kola-Kehinde O, Ruz P, et al.
Leukemia
. 2024 Aug;
38(10):2141-2149.
PMID: 39154059
Bruton's tyrosine kinase inhibitors (BTKi) have dramatic efficacy against B-cell malignancies, but link with cardiotoxicity, including atrial fibrillation (AF). Burden, severity, and implications of BTKi-related AF are unknown. Leveraging a...
9.
Makram O, Okwuosa T, Addison D, Cortes J, Dent S, Bevel M, et al.
J Am Heart Assoc
. 2024 Jul;
13(15):e035500.
PMID: 39056333
Background: Both cancer and cardiovascular disease (CVD) are the leading causes of death worldwide. Although our previous study detected a relationship between CVD and cancer incidence, limited evidence is available...
10.
Krishan S, Asad Z, Quiroga D, Ghazi S, Quartermaine C, Braunstein Z, et al.
Sci Rep
. 2024 Jul;
14(1):16829.
PMID: 39039091
Hematopoietic stem cell transplantation (HSCT) is a potentially curative therapy for several malignant and non-malignant hematologic conditions. However, patients undergoing HSCT are at increased risk of developing serious cardiovascular events....